Weatherly Asset Management L. P. Eli Lilly & CO Transaction History

Weatherly Asset Management L. P.

$1.16 Billion
Q2 2025

A detailed history of Weatherly Asset Management L. P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Weatherly Asset Management L. P. holds 285,844 shares of LLY stock, worth $213 Million. This represents 19.23% of its overall portfolio holdings.

Number of Shares

285,844

Previous 289,594 1.29%

Holding current value

$213 Million

Previous $239 Million 6.84%

% of portfolio

19.23%

Previous 21.68%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$713.71 - $898.95 $2.68 Million - $3.37 Million	-3,750 Reduced 1.29%	285,844 $223 Million
Q1 2025 May 01, 2025	SELL	$725.72 - $929.72 $812,080 - $1.04 Million	-1,119 Reduced 0.38%	289,594 $239 Million
Q4 2024 Jan 29, 2025	SELL	$727.2 - $932.06 $3.07 Million - $3.93 Million	-4,215 Reduced 1.43%	290,713 $224 Million
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $841,632 - $1.05 Million	-1,090 Reduced 0.37%	294,928 $261 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $1.1 Million - $1.38 Million	-1,518 Reduced 0.51%	296,018 $268 Million
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $507,515 - $678,983	-857 Reduced 0.29%	297,536 $231 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $2.62 Million - $3.09 Million	-4,990 Reduced 1.64%	298,393 $174 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $318,200 - $438,687	-732 Reduced 0.24%	303,383 $163 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $769,874 - $1.03 Million	-2,195 Reduced 0.72%	304,115 $143 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $52,807 - $62,019	-170 Reduced 0.06%	306,310 $105 Million
Q4 2022 Jan 10, 2023	SELL	$321.55 - $374.67 $68,811 - $80,179	-214 Reduced 0.07%	306,480 $0
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $2.45 Million - $2.79 Million	8,250 Added 2.76%	306,694 $99.2 Million
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $107,311 - $125,998	385 Added 0.13%	298,444 $96.8 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $362,596 - $450,614	-1,545 Reduced 0.52%	298,059 $85.4 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $55,088 - $68,364	-245 Reduced 0.08%	299,604 $82.8 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 0.1%	299,849 $68.8 Million
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $20,540 - $26,590	-125 Reduced 0.04%	300,149 $56.1 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $850,599 - $1.13 Million	-6,520 Reduced 2.13%	300,274 $50.7 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $259,540 - $300,205	-1,775 Reduced 0.58%	306,794 $45.4 Million
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $1.88 Million - $2.26 Million	-13,750 Reduced 4.27%	308,569 $50.7 Million
Q1 2020 May 01, 2020	SELL	$119.05 - $147.35 $11,428 - $14,145	-96 Reduced 0.03%	322,319 $44.7 Million
Q4 2019 Jan 23, 2020	BUY	$106.92 - $132.43 $18,176 - $22,513	170 Added 0.05%	322,415 $42.4 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $525,940 - $572,088	-4,925 Reduced 1.51%	322,245 $36 Million
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $22,158 - $25,864	-200 Reduced 0.06%	327,170 $36.2 Million
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $21,196 - $24,326	-280 Reduced 0.09%	327,370 $27.9 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $12,986 - $15,329	-175 Reduced 0.05%	327,650 $25.4 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $62,684 - $67,235	-765 Reduced 0.23%	327,825 $27.7 Million
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $25.3 Million - $28.1 Million	328,590	328,590 $28.1 Million

Others Institutions Holding LLY

# of Institutions

4,404

Shares Held

807M

Call Options Held

9.91M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weatherly Asset Management L. P., based on Form 13F filings with the SEC.

News

Stay updated on Weatherly Asset Management L. P. with notifications on news.

Account

Weatherly Asset Management L. P. Eli Lilly & CO Transaction History